Cynvenio Biosystems, Inc. is an emerging leader in the development of more affordable and clinically actionable precision medicine strategies for the individual cancer patient. Focused on rapid advancement in the molecular biology field, Cynvenio’s genomic tests accurately target known mutations in cancer-related genes to revolutionize personalized treatment decision making and clinical trial selection.
Among its breakthroughs is an expanding line of ClearID® tests engineered for greatly improved cancer detection and monitoring via a patient-friendly blood draw, and proprietary LiquidBiopsy® technology that makes real-time molecular characterization from whole blood a reality.
Cynvenio is based in Westlake Village, CA (Los Angeles). For more information, please visit www.cynvenio.com or www.clearidmonitoring.com.
Among its breakthroughs is an expanding line of ClearID® tests engineered for greatly improved cancer detection and monitoring via a patient-friendly blood draw, and proprietary LiquidBiopsy® technology that makes real-time molecular characterization from whole blood a reality.
Cynvenio is based in Westlake Village, CA (Los Angeles). For more information, please visit www.cynvenio.com or www.clearidmonitoring.com.
Phone: +1 888-885-1172
Total raised: $27.5M
Investors 1
| Date | Name | Website |
| - | UCLA Ventu... | ventures.u... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 05.06.2015 | Series B | $25.5M | - |
| 07.02.2012 | - | $2M | - |
Mentions in press and media 6
| Date | Title | Description |
| 18.06.2015 | Cynvenio Biosystems Completes $25.5M Series B Equity Financing | Cynvenio Biosystems, Inc., a Westlake Village, California-based developer of LiquidBiopsy technology for the genomic analysis of tumor cells from whole blood in support of cancer precision medicine strategies, completed a $25.5m Series B eq... |
| 17.06.2015 | Cynvenio Biosystems Finds $25.5M More For Cancer Diagnostics | Westlake Village-based Cynvenio Biosystems said Wednesday that it has raised $25.5M in a Series B funding round. The developer of life sciences equipment, used to profile cancer cells circulating in whole blood, came from Livzon Pharmaceuti... |
| 05.06.2015 | Cancer diagnostics maker Cynvenio Biosystems raises $25.5M | To provide cancer diagnostics, it extracts and isolates circulating tumor cells from the blood, then performs high throughput genomic analysis – a project it’s actually working on with Thermo Fisher Scientific. The funding will be used as w... |
| 07.02.2012 | Cynvenio Biosystems Raises $2.0M, Gets NCI Contracts | Westlake Village-based Cynvenio Biosystems, which is developing molecular diagnostics systems for cancer, announced this morning that it has received $2.0M in financing, plus scored two Small Business Innovative Research (SBIR) contracts fr... |
| 11.01.2010 | Cynvenio Biosystems Gets Nearly $2M | Westlake Village-based Cynvenio Biosystems, a developer of high speed, bioseparation instruments for the life sciences market, has raised $1.96M in a Series B funding round, according to a regulatory filing by the firm today. Source of the ... |
| - | Cancer diagnostics maker Cynvenio Biosystems raises $25.5M | Los Angeles cancer diagnostics maker Cynvenio Biosystems just raised $25.5 million, according to a regulatory filing. The company’s been positioning itself as a contender in the precision medicine game – helping physicians navigate cancer t... |